Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia

Clinical trial NCT07537738 · RECRUITING

Trial details

NCT number: NCT07537738
Sponsor: Peking University People's Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Acute Myeloid Leukemia (AML)MLL Rearrangement

Start date: 2025-06-01
Primary completion: 2026-04-07
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.